Celligenics is pleased to announce the close of our Series A fundraising exercise, raising $5.6 Mio, with Best World International (BWI) taking up at least a 12.5 per cent stake in our company.
Read More Here: https://www.straitstimes.com/business/companies-markets/best-world-investing-in-astar-biomedical-spin-off-celligenics
